Cardiac events and cardiac T2* in Egyptian children and young adults with beta-thalassemia major taking deferoxamine
Elalfy, Mohsen S; Abdin, Iman A; El Safy, Usama R; S. IBRAHIM, Ahmed; Ebeid, Fatma S; Salem, Doria S;
Abstract
Cardiac events and death are not uncommon in adults with beta-thalassemia (b-TM) taking deferoxamine (DFO) monotherapy because of poor compliance and possibly the less effectiveness of DFO in controlling cardiac iron overload. We sought to assess compliance with DFO, the percentage of shift to other iron chelators, and the occurrence of cardiac siderosis, and cardiac events and death in b-TM patients on DFO monotherapy.
Other data
| Title | Cardiac events and cardiac T2* in Egyptian children and young adults with beta-thalassemia major taking deferoxamine | Authors | Elalfy, Mohsen S ; Abdin, Iman A ; El Safy, Usama R ; S. IBRAHIM, Ahmed ; Ebeid, Fatma S ; Salem, Doria S | Issue Date | 2010 | Journal | Hematology/oncology and stem cell therapy | DOI | 4 174-8 3 |
PubMed ID | 21150236 |
Recommend this item
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.